A recent study reveals that the microRNA miR-362-3p acts as a powerful tumor suppressor in gastric cancer. Researchers found that high levels of miR-362-3p slow cancer cell growth, reduce migration, and prevent the epithelial-mesenchymal transition, which allows tumors to become more invasive.
The study showed that miR-362-3p directly targets DEP-1, a protein that promotes tumor growth in gastric cancer. By suppressing DEP-1, miR-362-3p inactivates the ERK signaling pathway, leading to decreased levels of Cyclin D1 and c-Myc, key proteins that drive cell proliferation. Overexpression of DEP-1 reversed the protective effects of miR-362-3p, confirming its central role in tumor progression.
These findings highlight the miR-362-3p/DEP-1/ERK axis as a promising target for new molecular therapies aimed at advanced gastric cancer, offering potential strategies to halt tumor growth and metastasis in patients resistant to current treatments.